Business & Economy · 31 views
GLP-1 drugs are fueling the rise of the 'big kids' market, one mega restaurant chain says
Diners on GLP-1 drugs are increasingly opting for smaller kids meals, said Cava CEO Brett Schulman.
Business & Economy 
Story intelligence
Coverage Single outlet Single-outlet story
Views 31 Community interest
Brief read Under 1 min brief 21 words
AI Summary
The trend of diners on GLP-1 drugs opting for smaller kids' meals is gaining traction, according to Cava CEO Brett Schulman.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Business & Economy
Continue reading recent Business & Economy coverage
- Former CIA official with Top Secret clearance admits to $194 million fraud, including 298 gold bars and four luxury South Florida propertiesContinue reading
- He manages one of the most successful soccer clubs in the world and is the elite leader every CEO wants to talk to. So why has Mikel Arteta decided to go publi…Continue reading
- My brother-in-law convinced his parents to sign over their home and life savings to buy a $3 million compound. Do I intervene?Continue reading
- Chart: A look at the S&P 500's remarkable and defiant trip to a new recordContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow